- PVLA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-Q/A Filing
Palvella Therapeutics (PVLA) 10-Q/A2017 Q2 Quarterly report (amended)
Filed: 26 Apr 18, 12:00am
Date: April 26, 2018 | /s/ Stephen S. Yoder | |
Stephen S. Yoder | ||
Title: Chief Executive Officer and President (principal executive officer) |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.